GIP Medications Gastrointestinal Discomfort: Similar to GLP-1 medications, GIP drugs may cause nausea and gastrointestinal issues
What we bring to the table as ADM is we bring the best in class ingredient portfolio to meet these needs
For most people yes
Disclosures: Davide Panzeri: Nothing to Disclose, Luca Di Tommaso: Nothing to Disclose, Donato Inverso: Nothing to Disclose, Laura Sironi: Nothing to Disclose 2557 CAS9 3-BASE & PAM OFFSET (C3PO) DETECTION INCREASES DELETION EFFICIENCY TO HELP STUDY PNPLA3 MUTANT KNOCKOUTS IN HUH7 CELLS Chinmay Raut 1 Rawdat Hussain 2 Akram Irshaid 2 Prabhu Ponnandy 2 Elizabeth Speliotes 3 , 1 University of Michgan Ann Arbor, 2 University of Michigan Ann Arbor, 3 University of Michigan Medical Center Background: PNPLA3 I148M is associated with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH)
Before initiating Wegovy in a patient with ADHD, clinicians should conduct a comprehensive medical assessment including: Medication review : Document all current ADHD medications, doses, and any other prescribed or over-the-counter treatments Cardiovascular assessment : Measure blood pressure and heart rate
11 De LucasM
